This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (403) Postoperative Monitoring and Telemonitoring (190) Coronary Heart Disease (109)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50091, first published .
Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial

Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial

Intravenous Ascorbic Acid for the Prevention of Postreperfusion Syndrome in Orthotopic Liver Transplantation: Protocol for a Randomized Controlled Trial

Authors of this article:

Luis Gajate1 Author Orcid Image ;   Inés de la Hoz1 Author Orcid Image ;   Mercedes Espiño2 Author Orcid Image ;   Maria del Carmen Martin Gonzalez1 Author Orcid Image ;   Cristina Fernandez Martin1 Author Orcid Image ;   Ascensión Martín-Grande1 Author Orcid Image ;   Diego Parise Roux1 Author Orcid Image ;   Oscar Pastor3 Author Orcid Image ;   Judith Villahoz1 Author Orcid Image ;   Miguel Ángel Rodriguez-Gandía4 Author Orcid Image ;   Javier Nuño Vazquez5 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics

Journals

  1. de Man A, Long M, Stoppe C. Vitamin C for all?. Current Opinion in Critical Care 2024;30(4):298 View
  2. Gajate Martín L, de la Hoz I, Martín M, Fernández C, Martín Grande A, Parise D, Villahoz J, Gómez M, Espiño M, Pastor O, Rodríguez Gandía M, Nuño J. A randomized trial of ascorbic acid for the prevention of post-reperfusion syndrome during liver transplantation. Hepatology Communications 2025;9(8) View